Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-17 Sale | 2023-03-21 7:06 pm | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 386 | $12.94 | $4,993 | 3,191 (Direct) | View |
| 2023-03-16 Sale | 2023-03-17 6:22 pm | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 187 | $13.43 | $2,511 | 11,536 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-15 Exercise | 2023-03-17 6:22 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 2,653 | $0 | 11,536 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:13 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 46,785 | $0 | 46,785 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 8:14 pm | N/A 2031-03-02 | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 14,300 | $0 | 14,300 (Direct) | View |
Ownership | 2020-10-15 8:14 pm | N/A 2027-11-28 | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs | 0 | $0 | 110,686 (Direct) | View |